List of Companies Profiled in the Report
• Bio-Techne (US)
• NanoFCM Inc. (UK)
• System Biosciences, LLC. (US)
• Capital Biosciences, Inc. (US)
• AMSBIO (UK)
• INOVIQ (Australia)
• Direct Biologics LLC (US)
• Regeneus Ltd (Australia)
• CUREXSYS (Germany)
• Aegle Therapeutics (US)
• Mercy Bioanalytics (US)
• multimmune GmbH (Germany)
• RION (US)
• Exogenus Therapeutics (Portugal)
• Everzom (France)
• Kimera Labs (US)
• NanoSomiX, Inc. (US)
• Exonox Biosciences, Inc. (Taiwan)
• Capricor Therapeutics, Inc. (US)
• Evox Therapeutics (US)
• ILIAS Biologics Inc. (Korea)
• Bio-Techne (US)
• NanoFCM Inc. (UK)
• System Biosciences, LLC. (US)
• Capital Biosciences, Inc. (US)
• AMSBIO (UK)
• INOVIQ (Australia)
• Direct Biologics LLC (US)
• Regeneus Ltd (Australia)
• CUREXSYS (Germany)
• Aegle Therapeutics (US)
• Mercy Bioanalytics (US)
• multimmune GmbH (Germany)
• RION (US)
• Exogenus Therapeutics (Portugal)
• Everzom (France)
• Kimera Labs (US)
• NanoSomiX, Inc. (US)
• Exonox Biosciences, Inc. (Taiwan)
• Capricor Therapeutics, Inc. (US)
• Evox Therapeutics (US)
• ILIAS Biologics Inc. (Korea)